Bridgeway Capital Management, LLC Verastem, Inc. Transaction History

Bridgeway Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.92 - $11.16 $326,600 - $3.96 Million	355,000 New	355,000 $302,000
Q2 2020 Aug 14, 2020	SELL	$1.69 - $4.2 $387,010 - $961,800	-229,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.25 - $3.14 $181,375 - $455,614	145,100 Added 172.94%	229,000 $346,000
Q4 2018 Feb 14, 2019	SELL	$3.23 - $7.01 $8,398 - $18,226	-2,600 Reduced 3.01%	83,900 $282,000
Q3 2018 Nov 13, 2018	SELL	$6.86 - $9.97 $611,226 - $888,327	-89,100 Reduced 50.74%	86,500 $627,000
Q2 2018 Aug 14, 2018	SELL	$2.88 - $8.67 $151,488 - $456,042	-52,600 Reduced 23.05%	175,600 $1.21 Million
Q3 2017 Nov 14, 2017	BUY	$3.01 - $5.41 $686,882 - $1.23 Million	228,200	228,200 $1.07 Million

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.12B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.